Poland

US firm Eli Lilly has suspended importation of its schizophrenia drug Zyprexa (olanzapine) because the Polish Ministry of Health imposed an unacceptably low price for the product... 2006-07-13

Poland is set to become "scientifically proficient" by 2020, thereby becoming increasingly attractive to foreign direct investment (FDI), according to The Global Technology Revolution... 2006-06-20

The Polish Pharmaceutical Chamber has pushed back the publishing of the country's new reimbursement list from mid-June to July 2006, to the annoyance of doctors, patients and manufacturers.... 2006-06-19

Polish firm Bioton has purchased a 21.1% stake in Indar - Ukraine's only local producer of insulin - for PLN10.1mn (US$3.3mn). Indar has a 70% market share in its domestic market... 2006-06-02

Poland's Justice Minister has announced an investigation into alleged corrupt practices by pharmaceutical companies in the country. The inquiry follows a complaint against the Polish... 2006-06-02

In the first quarter of this year, medicine and parapharmaceutical advertising spending in Poland increased by 4% year-on-year (y-o-y) reach PLN136mn (US$44.4mn), according to the... 2006-05-30

Torfarm - a Polish pharmaceutical distributor - is to invest PLN150mn (US$49mn) in new acquisitions over the next two years, with the aim of becoming the largest distributor in Poland.... 2006-05-23

Indian generic drugmaker Strides Arcolab has completed its acquisition of a steriles manufacturing facility in Poland. The move is likely to give the company a foothold in Eastern... 2006-05-19

The Polish pharmaceutical market had been growing steadily over the last five years. However, this growth rate has recently slowed down, and BMI predicts that this trend will continue... 2006-05-08

Poland is set to reform its under-funded healthcare system in May, following protests in April by doctors over their inadequate